- Home
- AYTU vs MTR Comparison
AYTU vs MTR Comparison
Compare AYTU & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- MTR
- Stock Information
- Founded
- AYTU N/A
- MTR 1979
- Country
- AYTU United States
- MTR United States
- Employees
- AYTU N/A
- MTR N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- AYTU Health Care
- MTR Energy
- Exchange
- AYTU Nasdaq
- MTR Nasdaq
- Market Cap
- AYTU 9.6M
- MTR 9.4M
- IPO Year
- AYTU N/A
- MTR N/A
- Fundamental
- Price
- AYTU $2.21
- MTR $5.55
- Analyst Decision
- AYTU Strong Buy
- MTR
- Analyst Count
- AYTU 2
- MTR 0
- Target Price
- AYTU $10.00
- MTR N/A
- AVG Volume (30 Days)
- AYTU 663.3K
- MTR 171.6K
- Earning Date
- AYTU 05-14-2025
- MTR 01-01-0001
- Dividend Yield
- AYTU N/A
- MTR 3.80%
- EPS Growth
- AYTU N/A
- MTR N/A
- EPS
- AYTU N/A
- MTR 0.23
- Revenue
- AYTU $81,659,000.00
- MTR $668,826.00
- Revenue This Year
- AYTU N/A
- MTR N/A
- Revenue Next Year
- AYTU $8.68
- MTR N/A
- P/E Ratio
- AYTU N/A
- MTR $24.16
- Revenue Growth
- AYTU 0.41
- MTR N/A
- 52 Week Low
- AYTU $0.95
- MTR $4.70
- 52 Week High
- AYTU $2.96
- MTR $10.42
- Technical
- Relative Strength Index (RSI)
- AYTU 63.18
- MTR 49.83
- Support Level
- AYTU $2.04
- MTR $5.06
- Resistance Level
- AYTU $2.40
- MTR $10.42
- Average True Range (ATR)
- AYTU 0.14
- MTR 0.89
- MACD
- AYTU 0.00
- MTR -0.08
- Stochastic Oscillator
- AYTU 54.90
- MTR 10.48
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.